Bahrain bans painkiller
Manama, December 15, 2010
Bahrain has banned the use of the painkilling drug, Distalgesic, health officials have declared.
The move follows the US Food and Drug Administration barring the drug after revelations it had a negative effect on blood vessels and could lead to heart disease and disease of the circulatory system.
A Health Ministry spokesman said all of Bahrain’s pharmacies had been asked to
immediately withdraw the drug from its shelves.
“We have also, with immediate effect, stopped stocking the drug at all health centres and hospitals and have banned its imports,” he said.-TradeArabia News Service
More Health & Environment Stories
- Ooredoo, Messi team up for children’s health
- Elan buys $40m stake in Dubai pharma group
- BA wins top business ethics awards
- MAF Dalkia inks service deal for TDIC project
- Schneider Electric unveils new solar products
- Abu Dhabi taps into non-oil sectors for growth
- Bahrain, Saudi hospitals in transplant tie-up
- Ministry in new major green IT campaign
- Egypt charity launches thalassemia campaign
- Disease focus for Dubai cardio summit